Clinical features and prognostic factors in 71 eyes over 20 years from patients with Coats’ disease in Korea

Abstract This retrospective study assesses the clinical features, treatment strategies, and long-term outcomes of patients with Coats’ disease in Korea. Multimodal imaging and medical records of consecutive patients treated between July 2000 and April 2020 at two tertiary centers were evaluated base...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hyun Goo Kang, Jung Dong Kim, Eun Young Choi, Suk Ho Byeon, Sung Soo Kim, Hyoung Jun Koh, Min Kim
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/f1db970c91104ad99c0829882125cf7d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f1db970c91104ad99c0829882125cf7d
record_format	dspace
spelling	oai:doaj.org-article:f1db970c91104ad99c0829882125cf7d2021-12-02T16:30:18ZClinical features and prognostic factors in 71 eyes over 20 years from patients with Coats’ disease in Korea10.1038/s41598-021-85739-92045-2322https://doaj.org/article/f1db970c91104ad99c0829882125cf7d2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85739-9https://doaj.org/toc/2045-2322Abstract This retrospective study assesses the clinical features, treatment strategies, and long-term outcomes of patients with Coats’ disease in Korea. Multimodal imaging and medical records of consecutive patients treated between July 2000 and April 2020 at two tertiary centers were evaluated based on onset age (adult vs. childhood [< 18 years]). Factors associated with final visual acuity (VA) and risk of treatment failure were assessed. A total of 71 eyes of 67 patients were included, with subgrouping by onset age showing 45% childhood and 55% adult cases. Overall, Stage 2 disease was most common at presentation (76%), though childhood cases had more Stage 3b (22% vs. 3%, P = 0.02) and greater clock hours of retinal telangiectasia (7 vs. 5, P = 0.005). First-line treatment included laser (25%), combined laser/anti-VEGF (23%), cryotherapy (20%), surgery (16%), and anti-VEGF only (9%). Cryotherapy was associated with a higher risk for secondary interventions (OR 11.8, P < 0.001), required in 56% overall. Despite a 3-line VA decrease in 34% overall, adult cases had superior final VA (P = 0.037). Multivariable regression showed that the number of anti-VEGF injections performed during the initial treatment period was associated with a 9.4 letter improvement in vision (P = 0.041). We observed a higher proportion of adult-onset Coats’ disease than previously reported in other non-Asian populations. An aggressive treatment with the addition of anti-VEGF may yield the most favorable long-term visual outcomes.Hyun Goo KangJung Dong KimEun Young ChoiSuk Ho ByeonSung Soo KimHyoung Jun KohMin KimNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Hyun Goo Kang Jung Dong Kim Eun Young Choi Suk Ho Byeon Sung Soo Kim Hyoung Jun Koh Min Kim Clinical features and prognostic factors in 71 eyes over 20 years from patients with Coats’ disease in Korea
description	Abstract This retrospective study assesses the clinical features, treatment strategies, and long-term outcomes of patients with Coats’ disease in Korea. Multimodal imaging and medical records of consecutive patients treated between July 2000 and April 2020 at two tertiary centers were evaluated based on onset age (adult vs. childhood [< 18 years]). Factors associated with final visual acuity (VA) and risk of treatment failure were assessed. A total of 71 eyes of 67 patients were included, with subgrouping by onset age showing 45% childhood and 55% adult cases. Overall, Stage 2 disease was most common at presentation (76%), though childhood cases had more Stage 3b (22% vs. 3%, P = 0.02) and greater clock hours of retinal telangiectasia (7 vs. 5, P = 0.005). First-line treatment included laser (25%), combined laser/anti-VEGF (23%), cryotherapy (20%), surgery (16%), and anti-VEGF only (9%). Cryotherapy was associated with a higher risk for secondary interventions (OR 11.8, P < 0.001), required in 56% overall. Despite a 3-line VA decrease in 34% overall, adult cases had superior final VA (P = 0.037). Multivariable regression showed that the number of anti-VEGF injections performed during the initial treatment period was associated with a 9.4 letter improvement in vision (P = 0.041). We observed a higher proportion of adult-onset Coats’ disease than previously reported in other non-Asian populations. An aggressive treatment with the addition of anti-VEGF may yield the most favorable long-term visual outcomes.
format	article
author	Hyun Goo Kang Jung Dong Kim Eun Young Choi Suk Ho Byeon Sung Soo Kim Hyoung Jun Koh Min Kim
author_facet	Hyun Goo Kang Jung Dong Kim Eun Young Choi Suk Ho Byeon Sung Soo Kim Hyoung Jun Koh Min Kim
author_sort	Hyun Goo Kang
title	Clinical features and prognostic factors in 71 eyes over 20 years from patients with Coats’ disease in Korea
title_short	Clinical features and prognostic factors in 71 eyes over 20 years from patients with Coats’ disease in Korea
title_full	Clinical features and prognostic factors in 71 eyes over 20 years from patients with Coats’ disease in Korea
title_fullStr	Clinical features and prognostic factors in 71 eyes over 20 years from patients with Coats’ disease in Korea
title_full_unstemmed	Clinical features and prognostic factors in 71 eyes over 20 years from patients with Coats’ disease in Korea
title_sort	clinical features and prognostic factors in 71 eyes over 20 years from patients with coats’ disease in korea
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/f1db970c91104ad99c0829882125cf7d
work_keys_str_mv	AT hyungookang clinicalfeaturesandprognosticfactorsin71eyesover20yearsfrompatientswithcoatsdiseaseinkorea AT jungdongkim clinicalfeaturesandprognosticfactorsin71eyesover20yearsfrompatientswithcoatsdiseaseinkorea AT eunyoungchoi clinicalfeaturesandprognosticfactorsin71eyesover20yearsfrompatientswithcoatsdiseaseinkorea AT sukhobyeon clinicalfeaturesandprognosticfactorsin71eyesover20yearsfrompatientswithcoatsdiseaseinkorea AT sungsookim clinicalfeaturesandprognosticfactorsin71eyesover20yearsfrompatientswithcoatsdiseaseinkorea AT hyoungjunkoh clinicalfeaturesandprognosticfactorsin71eyesover20yearsfrompatientswithcoatsdiseaseinkorea AT minkim clinicalfeaturesandprognosticfactorsin71eyesover20yearsfrompatientswithcoatsdiseaseinkorea
_version_	1718383968994197504

Clinical features and prognostic factors in 71 eyes over 20 years from patients with Coats’ disease in Korea

Ejemplares similares